Screening of Lactose Intolerance Among IBS Patients Diarrhea Dominant
Screening for Lactose Intolerance Among Patients With IBS Diarrhea Dominant
1 other identifier
observational
70
0 countries
N/A
Brief Summary
This cross-sectional study aims to determine the prevalence of lactose intolerance among patients with chronic diarrhea, assess its correlation with age and gender, and evaluate common symptoms in affected patients. The study will collect demographic data, conduct lactose intolerance testing via PCR, and use a symptom questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2025
CompletedFirst Posted
Study publicly available on registry
April 17, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
January 6, 2026
January 1, 2026
1 year
April 9, 2025
January 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence data on lactose intolerance in patients with IBS diarrhea dominant.
The primary outcome is to determine the percentage of patients with chronic diarrhea who test positive for lactose intolerance using PCR testing.
1 year
Study Arms (1)
adult patients aged 18-70 years diagnosed as IBS diarrhea dominant
The target population comprises individuals who meet the following inclusion criteria: Adults aged between 18 and 70 years. Diagnosed with IBS diarrhea dominant Both males and females are eligible for participation.
Eligibility Criteria
The study population consists of adult patients aged 18-70 years diagnosed with chronic diarrhea lasting more than four weeks. Both male and female participants are included. Participants will be recruited from a single healthcare center. They will undergo comprehensive assessments, including demographic profiling, medical history review, and diagnostic testing for lactose intolerance using PCR. The diversity in age and gender ensures that potential correlations with these variables can be analyzed.
You may qualify if:
- All Patients with IBS diarrhea dominant type meet Rome criteria attending at Al-Rajhy University Hospital during 6 months (from march to September). A patient must have recurrent abdominal pain (at least 1 day per week in the last 3 months) associated with at least two of the following:
- Related to defecation (pain improves or worsens with bowel movements).
- Change in stool frequency (diarrhea or constipation).
- Change in stool form (appearance) (loose, watery, hard, or lumpy).
- Patients aged \>18 years.
- Both males and females
You may not qualify if:
- patient aged\<18 years old.
- Patients with chronic diarrhea don't meet Rome criteria
- patients with malignancies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident at the tropical medicine department
Study Record Dates
First Submitted
April 9, 2025
First Posted
April 17, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
January 6, 2026
Record last verified: 2026-01